MatsukiyoCocokara & Co. (MSMKF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
MatsukiyoCocokara & Co. (MSMKF) with AI Score 49/100 (Weak). MatsukiyoCocokara & Co. operates a chain of drug stores and pharmacies across Japan. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 16, 2026MatsukiyoCocokara & Co. (MSMKF) Healthcare & Pipeline Overview
MatsukiyoCocokara & Co. is a leading drug store and pharmacy chain in Japan, operating over 1,700 stores across 47 prefectures. With a focus on healthcare retail, the company leverages its extensive network and established brand to serve a broad customer base in the Japanese market.
Investment Thesis
MatsukiyoCocokara & Co. presents a stable investment opportunity within the Japanese healthcare retail market. The company's established network of over 1,700 stores provides a strong foundation for consistent revenue generation. With a P/E ratio of 17.62 and a profit margin of 5.1%, the company demonstrates reasonable profitability. The dividend yield of 1.89% offers a steady income stream for investors. Growth catalysts include expanding product offerings and enhancing online presence. Potential risks include increasing competition from other drug store chains and evolving consumer preferences. The company's beta of -0.21 suggests low volatility compared to the broader market.
Based on FMP financials and quantitative analysis
Key Highlights
- Operates 1,726 stores across 47 prefectures in Japan as of June 30, 2020, providing extensive market coverage.
- P/E ratio of 17.62 indicates a reasonable valuation compared to earnings.
- Profit margin of 5.1% reflects the company's ability to generate profits from its operations.
- Gross margin of 35.2% demonstrates effective cost management in product sales.
- Dividend yield of 1.89% offers a consistent income stream for investors.
Competitors & Peers
Strengths
- Extensive store network across Japan.
- Established brand reputation.
- Wide range of products and services.
- Strong relationships with suppliers.
Weaknesses
- Reliance on the Japanese market.
- Exposure to regulatory changes in the healthcare industry.
- Competition from other drug store chains.
- Vulnerability to economic downturns.
Catalysts
- Upcoming: Expansion of online platform to increase reach and sales.
- Ongoing: Increasing private label product offerings to improve profitability.
- Ongoing: Strategic acquisitions to expand store network and market share.
- Ongoing: Focusing on preventative healthcare to capitalize on growing trend.
- Upcoming: Launch of new health and wellness product lines.
Risks
- Ongoing: Increasing competition from other drug store chains.
- Potential: Changing consumer preferences and demand.
- Potential: Economic slowdown impacting consumer spending.
- Potential: Regulatory changes in the healthcare industry.
- Ongoing: Dependence on the Japanese market.
Growth Opportunities
- Expanding online presence: MatsukiyoCocokara & Co. can capitalize on the growing e-commerce trend by expanding its online platform and offering online ordering and delivery services. This would allow the company to reach a broader customer base and increase sales. The e-commerce market in Japan is expected to continue growing, providing a significant opportunity for MatsukiyoCocokara & Co. to increase its market share. Timeline: Ongoing.
- Increasing private label product offerings: MatsukiyoCocokara & Co. can increase its profitability by expanding its private label product offerings. Private label products typically have higher margins than branded products, allowing the company to improve its overall profitability. The market for private label products is growing in Japan, as consumers become more price-conscious. Timeline: Ongoing.
- Strategic acquisitions: MatsukiyoCocokara & Co. can pursue strategic acquisitions to expand its store network and market share. Acquiring smaller drug store chains or pharmacies would allow the company to quickly increase its presence in new markets and gain access to new customers. The Japanese drug store market is fragmented, providing opportunities for consolidation. Timeline: Ongoing.
- Focusing on preventative healthcare: MatsukiyoCocokara & Co. can capitalize on the growing trend of preventative healthcare by offering a wider range of preventative healthcare products and services. This could include vitamins, supplements, and health screenings. The market for preventative healthcare products and services is growing in Japan, as consumers become more health-conscious. Timeline: Ongoing.
- Expanding into new geographic markets: MatsukiyoCocokara & Co. can explore opportunities to expand into new geographic markets outside of Japan. This would allow the company to diversify its revenue streams and reduce its reliance on the Japanese market. The global healthcare retail market is growing, providing opportunities for MatsukiyoCocokara & Co. to expand its international presence. Timeline: Future
Opportunities
- Expanding online presence.
- Increasing private label product offerings.
- Strategic acquisitions.
- Focusing on preventative healthcare.
Threats
- Increasing competition.
- Changing consumer preferences.
- Economic slowdown.
- Regulatory changes.
Competitive Advantages
- Extensive store network across Japan provides a competitive advantage.
- Established brand reputation and customer loyalty.
- Strong relationships with pharmaceutical suppliers.
- Efficient supply chain and distribution network.
About MSMKF
MatsukiyoCocokara & Co. was founded in 1932 and has grown to become a prominent drug store and pharmacy chain in Japan. The company operates a network of 1,726 stores as of June 30, 2020, spanning all 47 prefectures of Japan. These stores offer a wide range of products and services, including prescription drugs, over-the-counter medications, health and beauty products, and daily necessities. MatsukiyoCocokara & Co. aims to provide convenient access to healthcare and wellness products for its customers. The company has strategically expanded its store network and product offerings to meet the evolving needs of the Japanese market. MatsukiyoCocokara & Co. competes with other drug store chains and pharmacies in Japan, focusing on customer service, product selection, and store locations to maintain its competitive edge. The company is based in Matsudo, Japan, and continues to focus on strengthening its position in the Japanese healthcare retail sector.
What They Do
- Operates a chain of drug stores and pharmacies.
- Sells prescription drugs.
- Offers over-the-counter medications.
- Provides health and beauty products.
- Sells daily necessities.
- Offers healthcare and wellness products.
Business Model
- Generates revenue through the sale of products in its stores.
- Prescription drug sales contribute a significant portion of revenue.
- Over-the-counter medications and health/beauty products also drive sales.
- The company leverages its store network to reach a broad customer base.
Industry Context
MatsukiyoCocokara & Co. operates within the competitive Japanese healthcare retail market. The industry is characterized by a large number of drug store chains and pharmacies, all vying for market share. Key trends include an aging population, increasing healthcare awareness, and growing demand for health and beauty products. The company competes with other major players such as CSMYF, KYKOF, RADLY, SHTDF, and SHTDY. MatsukiyoCocokara & Co. differentiates itself through its extensive store network, product selection, and customer service.
Key Customers
- Individual consumers seeking healthcare and wellness products.
- Patients requiring prescription medications.
- Customers looking for over-the-counter remedies.
- Individuals purchasing health and beauty products.
Financials
Chart & Info
MatsukiyoCocokara & Co. (MSMKF) stock price: Price data unavailable
Latest News
No recent news available for MSMKF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MSMKF.
Price Targets
Wall Street price target analysis for MSMKF.
MoonshotScore
What does this score mean?
The MoonshotScore rates MSMKF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Kiyoo Matsumoto
CEO
Kiyoo Matsumoto serves as the CEO of MatsukiyoCocokara & Co., leading a workforce of 13,371 employees. His background includes extensive experience in the retail and healthcare sectors. He has held various leadership positions within the company, contributing to its growth and expansion. Matsumoto's expertise lies in strategic planning, operational efficiency, and customer relationship management. He is committed to driving innovation and enhancing the company's competitive position in the Japanese market. His leadership is focused on delivering value to shareholders and providing high-quality products and services to customers.
Track Record: Under Kiyoo Matsumoto's leadership, MatsukiyoCocokara & Co. has expanded its store network and enhanced its product offerings. He has overseen the implementation of key strategic initiatives aimed at improving operational efficiency and customer satisfaction. Matsumoto has also played a crucial role in fostering a culture of innovation and collaboration within the company. His leadership has contributed to the company's consistent financial performance and its strong position in the Japanese healthcare retail market.
MSMKF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that MatsukiyoCocokara & Co. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the potential for limited information and liquidity compared to exchange-listed securities.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases information asymmetry.
- Lower trading volume can lead to price volatility.
- Wider bid-ask spreads increase transaction costs.
- Potential for fraud or manipulation is higher on the OTC market.
- OTC Other stocks may be subject to delisting or trading suspensions.
- Verify the company's registration and regulatory filings.
- Review the company's financial statements, if available.
- Assess the company's management team and track record.
- Research the company's industry and competitive landscape.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any news or legal proceedings involving the company.
- Established history of operations in Japan since 1932.
- Extensive network of over 1,700 stores across Japan.
- Significant market capitalization of $7.23B.
- Positive profit margin of 5.1%.
- Payment of dividends with a yield of 1.89%.
MSMKF Healthcare Stock FAQ
What does MatsukiyoCocokara & Co. do?
MatsukiyoCocokara & Co. operates as a leading drug store and pharmacy chain in Japan. The company's core business involves retailing prescription drugs, over-the-counter medications, health and beauty products, and daily necessities through its extensive network of over 1,700 stores across 47 prefectures. The company aims to provide convenient access to healthcare and wellness products for its customers, focusing on customer service, product selection, and store locations to maintain its competitive edge in the Japanese market.
What do analysts say about MSMKF stock?
AI analysis is currently pending for MSMKF, therefore an analyst consensus is not available. However, key valuation metrics include a P/E ratio of 17.62 and a dividend yield of 1.89%. Growth considerations involve expanding online presence, increasing private label product offerings, and pursuing strategic acquisitions. Risks include increasing competition from other drug store chains and evolving consumer preferences. Investors should conduct their own due diligence and consider their individual investment objectives before making any decisions.
What are the main risks for MSMKF?
The main risks for MatsukiyoCocokara & Co. include increasing competition from other drug store chains in Japan, which could impact market share and profitability. Changing consumer preferences and demand for healthcare products also pose a risk. An economic slowdown could reduce consumer spending and negatively affect sales. Regulatory changes in the healthcare industry could impact the company's operations and profitability. Additionally, the company's dependence on the Japanese market exposes it to economic and political risks specific to Japan.
What are the key factors to evaluate for MSMKF?
MatsukiyoCocokara & Co. (MSMKF) currently holds an AI score of 49/100, indicating low score. Key strength: Extensive store network across Japan.. Primary risk to monitor: Ongoing: Increasing competition from other drug store chains.. This is not financial advice.
How frequently does MSMKF data refresh on this page?
MSMKF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven MSMKF's recent stock price performance?
Recent price movement in MatsukiyoCocokara & Co. (MSMKF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Extensive store network across Japan.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider MSMKF overvalued or undervalued right now?
Determining whether MatsukiyoCocokara & Co. (MSMKF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying MSMKF?
Before investing in MatsukiyoCocokara & Co. (MSMKF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on information available as of 2020 and may not reflect current performance.
- OTC market data may be limited and less reliable than exchange-listed data.
- AI analysis is pending and may provide further insights.